Adar1 Capital Management, LLC Top Holdings and 13F Report (2026)

About Adar1 Capital Management, LLC

Investment Activity

Adar1 Capital Management, LLC has $1.70 billion in total holdings as of March 31, 2026.
Adar1 Capital Management, LLC owns shares of 300 different stocks, but just 61 companies or ETFs make up 80% of its holdings.
Approximately 33.12% of the portfolio was purchased this quarter.
About 14.09% of the portfolio was sold this quarter.
This quarter, Adar1 Capital Management, LLC has purchased 256 new stocks and bought additional shares in 97 stocks.
Adar1 Capital Management, LLC sold shares of 64 stocks and completely divested from 31 stocks this quarter.

Largest Holdings

ABIVAX SA: $160,123,416
Protagonist Therapeutics: $104,780,143
Roivant Sciences: $91,019,596
Immunovant: $66,546,608
Terns Pharmaceuticals: $58,766,931

Largest New Holdings this Quarter

07373V105 - Beam Therapeutics: $34,467,116 Holding
92764N102 - Vir Biotechnology: $24,592,637 Holding
23306J309 - DBV TECHNOLOGIES S A: $21,158,771 Holding
G4444S107 - HELIX ACQUISITION CORP III: $10,300,000 Holding
61559X104 - MoonLake Immunotherapeutics: $8,893,834 Holding

Largest Purchases this Quarter

Denali Therapeutics: 1,819,339 shares (about $34.93M)
Beam Therapeutics: 1,446,375 shares (about $34.47M)
Terns Pharmaceuticals: 573,084 shares (about $30.21M)
Crinetics Pharmaceuticals: 829,963 shares (about $30.14M)
Vir Biotechnology: 2,744,714 shares (about $24.59M)

Largest Sales this Quarter

Arbutus Biopharma: 2,281,934 shares (about $10.27M)
CRESCENT BIOPHARMA INC.: 555,727 shares (about $10.21M)
Fulcrum Therapeutics: 1,188,189 shares (about $9.11M)
BridgeBio Pharma: 119,122 shares (about $8.85M)
Teleflex: 59,441 shares (about $7.11M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
ABIVAX SA	$160,123,416	$13,438,832 â–²	9.2%	1,438,019	9.4%	SPONSORED ADS
PTGX Protagonist Therapeutics	$104,780,143	$5,802,165 â–¼	-5.2%	994,119	6.2%	Medical
ROIV Roivant Sciences	$91,019,596	$3,962,651 â–¼	-4.2%	3,285,906	5.4%	Medical
IMVT Immunovant	$66,546,608	$4,919,363 â–²	8.0%	2,679,010	3.9%	Medical
TERN Terns Pharmaceuticals	$58,766,931	$30,212,988 â–²	105.8%	1,114,699	3.5%	Medical
SPY SPDR S&P 500 ETF Trust	$49,386,820	$13,823,627 â–²	38.9%	75,940	2.9%	Finance
CYTK Cytokinetics	$41,691,766	$6,089,425 â–²	17.1%	632,556	2.5%	Medical
CRNX Crinetics Pharmaceuticals	$41,380,502	$30,144,256 â–²	268.3%	1,139,331	2.4%	Medical
BOXX Alpha Architect 1-3 Month Box ETF	$39,204,266		0.0%	337,125	2.3%	ETF
DNLI Denali Therapeutics	$35,931,936	$34,931,309 â–²	3,490.9%	1,871,455	2.1%	Medical
BEAM Beam Therapeutics	$34,467,116	$34,467,116 â–²	New Holding	1,446,375	2.0%	Medical
ZLAB Zai Lab	$26,811,153	$3,364,112 â–²	14.3%	1,425,367	1.6%	Medical
SEPTERNA INC	$26,188,327	$1,629,066 â–¼	-5.9%	1,089,818	1.5%	COM
VIR Vir Biotechnology	$24,592,637	$24,592,637 â–²	New Holding	2,744,714	1.4%	Medical
DBV TECHNOLOGIES S A	$21,158,771	$21,158,771 â–²	New Holding	1,012,866	1.2%	SPONSORED ADS
ANTERIS TECHNOLOGIES GLOBAL	$21,029,683	$14,154,471 â–²	205.9%	3,789,132	1.2%	COM
INSP Inspire Medical Systems	$20,900,061	$20,126,361 â–²	2,601.3%	405,197	1.2%	Medical
SRRK Scholar Rock	$20,021,541	$16,600,546 â–²	485.3%	407,273	1.2%	Medical
RYTM Rhythm Pharmaceuticals	$18,389,807	$13,923,984 â–²	311.8%	211,450	1.1%	Medical
SPYRE THERAPEUTICS INC	$17,065,012	$15,347,480 â–²	893.6%	338,323	1.0%	COM NEW
CTMX CytomX Therapeutics	$16,027,893	$4,101,121 â–¼	-20.4%	3,410,190	0.9%	Medical
PRTA Prothena	$15,371,626	$1,202,160 â–²	8.5%	1,581,443	0.9%	Medical
SNY Sanofi	$15,270,121	$12,211,944 â–²	399.3%	316,939	0.9%	Medical
PCVX Vaxcyte	$15,058,451	$3,283,506 â–¼	-17.9%	259,137	0.9%	Medical
MONOPAR THERAPEUTICS INC	$14,479,792	$1,663,972 â–²	13.0%	264,278	0.9%	COM NEW
ABUS Arbutus Biopharma	$14,099,288	$10,268,703 â–¼	-42.1%	3,133,175	0.8%	Medical
AMLX Amylyx Pharmaceuticals	$13,908,396	$1,532,447 â–²	12.4%	1,000,604	0.8%	Medical
CLDX Celldex Therapeutics	$13,570,324	$6,945,126 â–¼	-33.9%	427,816	0.8%	Medical
TSHA Taysha Gene Therapies	$13,318,048	$2,161,781 â–²	19.4%	2,979,429	0.8%	Medical
XENE Xenon Pharmaceuticals	$13,310,477	$1,449,680 â–²	12.2%	228,899	0.8%	Medical
SUTRO BIOPHARMA INC	$13,063,825	$11,392,937 â–²	681.8%	524,441	0.8%	COM SHS
RVMD Revolution Medicines	$13,021,094	$1,087,838 â–¼	-7.7%	133,893	0.8%	Medical
ELVN Enliven Therapeutics	$12,917,968	$11,741,968 â–²	998.5%	329,540	0.8%	Medical
REPL Replimune Group	$12,874,851	$3,187,487 â–²	32.9%	1,682,987	0.8%	Medical
CG ONCOLOGY INC	$12,568,108	$4,902,739 â–¼	-28.1%	185,699	0.7%	COM
BIL SPDR Bloomberg 1-3 Month T-Bill ETF	$12,425,009		0.0%	135,585	0.7%	ETF
ESTA Establishment Labs	$12,120,997	$2,387,656 â–²	24.5%	213,473	0.7%	Medical
IVA Inventiva	$12,067,909	$2,971,736 â–¼	-19.8%	2,174,398	0.7%	Medical
IONS Ionis Pharmaceuticals	$12,039,780	$991,789 â–²	9.0%	160,338	0.7%	Medical
NEKTAR THERAPEUTICS	$11,602,081	$6,419,451 â–²	123.9%	161,252	0.7%	COM NEW
INHIBIKASE THERAPEUTICS INC	$11,099,041	$2,448,393 â–¼	-18.1%	6,606,572	0.7%	COM NEW
SPRY ARS Pharmaceuticals	$10,933,134	$7,965,495 â–²	268.4%	1,361,536	0.6%	Medical
HELIX ACQUISITION CORP III	$10,300,000	$10,300,000 â–²	New Holding	1,000,000	0.6%	USD CL A ORD SHS
OVID Ovid Therapeutics	$10,087,931	$575,231 â–²	6.0%	4,544,113	0.6%	Medical
ONKURE THERAPEUTICS INC	$10,080,656	$5,882,042 â–²	140.1%	2,434,941	0.6%	COM CL A
REGN Regeneron Pharmaceuticals	$9,390,667	$79,582 â–²	0.9%	12,154	0.6%	Medical
MLTX MoonLake Immunotherapeutics	$8,893,834	$8,893,834 â–²	New Holding	477,137	0.5%	Medical
LEXEO THERAPEUTICS INC	$8,422,589	$425,845 â–²	5.3%	1,467,350	0.5%	COM
OPUS GENETICS INC	$8,412,968	$8,230,968 â–²	4,522.5%	1,849,004	0.5%	COM
TEVA Teva Pharmaceutical Industries	$8,083,937	$976,490 â–²	13.7%	268,391	0.5%	Medical
SVRA Savara	$7,996,361	$322,593 â–²	4.2%	1,464,535	0.5%	Medical
MAPLIGHT THERAPEUTICS INC	$7,621,900	$7,621,900 â–²	New Holding	374,909	0.4%	COM
LEONABIO INC	$7,478,505	$3,431,259 â–²	84.8%	727,481	0.4%	COM
EQ Equillium	$7,453,318	$3,762,838 â–¼	-33.5%	3,726,659	0.4%	Medical
VKTX Viking Therapeutics	$7,409,911	$6,547,796 â–²	759.5%	227,717	0.4%	Medical
DAMORA THERAPEUTICS INC	$7,226,100	$7,226,100 â–²	New Holding	279,000	0.4%	COM NEW
URGN Urogen Pharma	$7,110,353	$4,136,910 â–²	139.1%	395,459	0.4%	Medical
BBIO BridgeBio Pharma	$7,002,124	$8,846,000 â–¼	-55.8%	94,292	0.4%	Medical
PRIME MEDICINE INC	$6,867,021	$6,867,021 â–²	New Holding	1,973,282	0.4%	COM
IWM iShares Russell 2000 ETF	$6,820,000	$2,993,360 â–¼	-30.5%	27,500	0.4%	Finance
VRTX Vertex Pharmaceuticals	$6,731,591	$606,848 â–²	9.9%	15,075	0.4%	Medical
KORRO BIO INC	$6,113,411	$6,113,411 â–²	New Holding	540,054	0.4%	COM
VRDN Viridian Therapeutics	$5,954,494	$4,444,501 â–²	294.3%	304,422	0.4%	Medical
DHR Danaher	$5,864,707	$1,010,947 â–²	20.8%	30,932	0.3%	Medical
INSM Insmed	$5,787,300	$5,787,300 â–²	New Holding	35,392	0.3%	Medical
ASND Ascendis Pharma A/S	$5,721,452	$68,619 â–¼	-1.2%	25,014	0.3%	Medical
BHF Brighthouse Financial	$5,719,917		0.0%	95,523	0.3%	Finance
SRPT Sarepta Therapeutics	$5,702,382	$5,074,258 â–²	807.8%	262,058	0.3%	Medical
OAKTREE ACQUISITION CORP III	$5,500,533		0.0%	516,482	0.3%	UNIT 10/04/2029
PERCEPTIVE CAP SOLUTIONS COR	$5,480,404	$470,185 â–²	9.4%	499,581	0.3%	CL A ORD SHS
KRYS Krystal Biotech	$5,170,016		0.0%	20,014	0.3%	Medical
ABOS Acumen Pharmaceuticals	$5,088,948	$2,985,756 â–²	142.0%	2,156,334	0.3%	Medical
IVVD Invivyd	$4,969,155	$100,061 â–¼	-2.0%	3,822,427	0.3%	Medical
BRIDGEBIO PHARMA INC	$4,943,000	$4,943,000 â–²	New Holding	45,000	0.3%	NOTE 2.250% 2/0
BHAV ACQUISITION CORP	$4,935,000	$4,935,000 â–²	New Holding	495,000	0.3%	UNIT 03/18/2031
TARA Protara Therapeutics	$4,900,068	$1,022,655 â–¼	-17.3%	940,512	0.3%	Medical
BRIDGEBIO PHARMA INC	$4,852,000	$4,852,000 â–²	New Holding	30,000	0.3%	NOTE 1.750% 3/0
AGIO Agios Pharmaceuticals	$4,758,934	$1,601,106 â–¼	-25.2%	140,672	0.3%	Medical
LLY Eli Lilly and Company	$4,654,036	$4,654,036 â–²	New Holding	5,060	0.3%	Medical
DIANTHUS THERAPEUTICS INC	$4,615,600	$4,615,600 â–²	New Holding	55,000	0.3%	COM
ARWR Arrowhead Pharmaceuticals	$4,407,810	$758,670 â–²	20.8%	70,300	0.3%	Medical
BLTE Belite Bio	$4,285,747	$2,066,183 â–¼	-32.5%	26,880	0.3%	Medical
EVOMMUNE INC	$4,231,585		0.0%	184,062	0.2%	COM SHS
MLYS Mineralys Therapeutics	$4,190,444	$499,946 â–²	13.5%	154,686	0.2%	Medical
JANX Janux Therapeutics	$4,149,789	$738,007 â–²	21.6%	298,546	0.2%	Medical
ELYM Eliem Therapeutics	$4,093,985	$5,718,469 â–¼	-58.3%	597,662	0.2%	Medical
PALISADE BIO INC	$3,963,479	$455,000 â–²	13.0%	2,264,845	0.2%	COM
AMERICAN EXCEPTIONALISM ACQU	$3,872,147		0.0%	357,539	0.2%	ORD CL A
SPRUCE BIOSCIENCES INC	$3,829,510	$39,210 â–²	1.0%	58,600	0.2%	COM NEW
NAMS NewAmsterdam Pharma	$3,797,122		0.0%	118,623	0.2%	Medical
LQDA Liquidia	$3,774,000	$2,849,370 â–²	308.2%	100,000	0.2%	Medical
ZURA Zura Bio	$3,750,898	$406,611 â–²	12.2%	630,403	0.2%	Medical
ACLX Arcellx	$3,683,885	$68,892 â–²	1.9%	32,084	0.2%	Medical
CONTINEUM THERAPEUTICS INC	$3,613,193	$30,038 â–¼	-0.8%	276,661	0.2%	CL A
BRIDGEBIO PHARMA INC	$3,564,000	$3,564,000 â–²	New Holding	20,000	0.2%	NOTE 2.500% 3/1
GLUE Monte Rosa Therapeutics	$3,549,120		0.0%	215,752	0.2%	Medical
BEONE MEDICINES LTD	$3,474,846	$3,474,846 â–²	New Holding	11,701	0.2%	SPONSORED ADS
CRBP Corbus Pharmaceuticals	$3,444,074	$751,200 â–²	27.9%	366,781	0.2%	Medical
TENAX THERAPEUTICS INC	$3,413,257	$2,395,126 â–²	235.2%	213,462	0.2%	COM NEW
ARRIVENT BIOPHARMA INC	$3,271,649	$3,271,649 â–²	New Holding	141,814	0.2%	COM

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adar1 Capital Management, LLC Top Holdings and 13F Report (2026)

About Adar1 Capital Management, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adar1 Capital Management, LLC Top Holdings and 13F Report (2026)

About Adar1 Capital Management, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofAdar1 Capital Management, LLC

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools